Strength in struggle: unravelling the journey of national vector borne disease control programme India: a comprehensive SWOT analysis

Authors

  • Prabhjeet Kaur Consultant Technical Unit, India Primary Healthcare Support Initiative (IPSI), All India Institute of Medical Sciences, New Delhi, India
  • Preet Verma Consultant Technical Unit, India Primary Healthcare Support Initiative (IPSI), All India Institute of Medical Sciences, New Delhi, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20233543

Keywords:

Vector borne diseases, National Vector Borne Diseases Control Programme, SWOT analysis, Health programme, Malaria, Dengue

Abstract

India, like many other regions, faces the substantial burden of vector-borne diseases. Initially confined to tropical and sub-tropical regions, vector-borne diseases are now spreading to new geographies due to increasing unplanned urbanization, changes in land use, growing international travel, and the impact of climate and environmental dynamics. To address these challenges, India implemented the National Vector Borne Disease Control Program (NVBDCP) in 2003-04, which targets the prevention and control of the six vector-borne diseases. Over the years, numerous initiatives have been undertaken to combat the challenges posed by vector-borne diseases in India. The successes, such as streamlined resource utilization and the introduction of effective tools, have led to substantial reductions in disease burden. Nevertheless, issues like manpower shortages, logistical hurdles, and a lack of research resources remain as challenges. Moreover, the program must confront emerging threats posed by urbanization, climate change, and resistance to treatments. NVBDCP's roadmap for the future includes embracing opportunities like vaccine development, and research, as well as fostering collaborations with partners. By addressing its weaknesses and effectively managing the threats at hand, the program can continue its vital mission of combatting vector-borne diseases in India. The implementation of these strategies is essential to ensure the sustained success of disease control and prevention efforts in the country.

References

World Health Organization. Key facts: vector-borne diseases. Available at: https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases. Accessed on 02 October 2023.

World Health Organization. The Global vector control response 2017–2030 (GVCR). Available at: https://www.who.int/publications/i/item/9789241512978. Accessed on 02 October 2023.

National Centre for Vector Borne Diseases Control, Ministry of Health and Family Welfare, Government of India. Manual on Integrated Vector Management 2022. Available at: https://ncvbdc.mohfw.gov.in/ Doc/Guidelines/Manual-Integrated-Vector-Management-2022.pdf. Accessed on 02 October 2023.

National Centre for Vector Borne Disease Control, Ministry of Health and Family Welfare, Government of India. Integrated Vector Management. 2016. Available at: https://ncvbdc.mohfw.gov.in/Write ReadData/l892s/IVM%2010_March_2016.pdf. Accessed on 02 October 2023.

Government of India. Annual Report Disease Control Programmes 2015. Available at: https://nvbdcp.gov. in/Doc/Annual-report-NVBDCP-2014-15.pdf. Accessed on 02 October 2023.

National Institute of Malaria Research (NIMR). Guidelines for diagnosis and treatment of malaria in India. 2nd edition. New Delhi: NIMR. 2011.

National Drug Policy on malaria. Directorate of National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. 2013.

Mishra N, Singh JP, Srivastava B, Arora U, Shah NK, Ghosh SK, et al. Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010. Bull World Health Organ. 2012;90:895-904.

Anvikar AR, Arora U, Sonal GS, Mishra N, Shahi B, Savargaonkar D, et al. Antimalarial drug policy in India: past, present & future. Indian J Med Res. 2014;139(2):205-15.

Dua VK, Kar PK, Sharma VP. Chloroquine resistant Plasmodium vivax malaria in India. Trop Med Int Health. 1996;1:816-9.

Shah NK, Tyagi P, Sharma SK. Correction: The Impact of Artemisinin Combination Therapy and Long-Lasting Insecticidal Nets on Forest Malaria Incidence in Tribal Villages of India, 2006–2011. Plos One. 2013;8(10).

Sharma S, Goel K, Kaushal K, Grover GS, Dikid T, Singh GB. An Evaluation of Malaria Surveillance System in Punjab, India, 2020. Indian J Community Med. 2023;48(3):407-12.

National Vector Borne Disease Control Programme. National Framework for Malaria Elimination in India 2016-2030. Available at: https://www.nvbdcp.gov. in/WriteReadData/l892s/National-framework-for-malaria-elimination-in-India 2016%E2%80%9320 30.pdf. Accessed on 02 October 2023.

Singh MP, Rajvanshi H, Bharti PK, Das A, Thakre V, Jayswar H, et al. A qualitative study on community perceptions on quality of healthcare services they received in the Malaria Elimination Demonstration Project in district Mandla, India. Malar J. 2022;21(1):368.

National Centre for Vector Borne Diseases Control, Ministry of Health and Family Welfare, Government of India. Strategic Action Plan for Malaria 2012-17. Available at: https://ncvbdc.mohfw.gov.in/Doc/ Strategic-Action-Plan-Malaria-2012-17-Co.pdf. Accessed on 02 October 2023.

National Centre for Vector Borne Diseases Control, Ministry of Health and Family Welfare, Government of India. IMCP II Round 9 Proposal. Available at: https://ncvbdc.mohfw.gov.in/WriteReadData/l892s/IMCP-II-Round-9-proposal.pdf. Accessed on 02 October 2023.

Raghavendra K, Chourasia MK, Swain DK, Bhatt RM, Uragayala S, Dutta GDP, et al. Monitoring of long-lasting insecticidal nets (LLINs) coverage versus utilization: a community-based survey in malaria endemic villages of Central India. Malar J. 2017;16(1):467.

Rathi SK, Bhandari P. Strengths, weaknesses, opportunities, and threats analysis of the national vector-borne disease control program. Indian J Community Med. 2018;43(4):227-31.

Dev V, Barman K, Khound K. A cross-sectional study assessing the residual bio-efficacy and durability of field-distributed long-lasting insecticidal nets in malaria endemic ethnic communities of Assam, Northeast India. J Infect Public Health. 2016;9(3):298-307.

Passah M, Nengnong CB, Wilson ML, Carlton JM, Kharbamon L, Albert S. Implementation and acceptance of government-sponsored malaria control interventions in Meghalaya, India. Malar J. 2022;21(1):200.

Gunasekaran K, Sahu SS, Vijayakumar KN, Jambulingam P. Acceptability, willing to purchase and use long lasting insecticide treated mosquito nets in Orissa State, India. Acta Trop. 2009;112(2):149-55.

Arali PK, Shanbhag DN. Assessment of national vector borne disease control programme in state of Karnataka. Int J Community Med Public Health. 2019;6:525-32.

Prasad H. Evaluation of malaria control programme in three selected districts of Assam, India. J Vector Borne Dis. 2009;46:280-7.

Ghosh RS, Haldar P, Jacobson J. Lessons Learned from the Japanese Encephalitis Vaccine Introduction in India That Supported the Introduction of Ivermectin-Diethylcarbamazine-Albendazole for Lymphatic Filariasis Elimination. Am J Trop Med Hyg. 2022;106(5):48-55.

Valecha N. Keeping the momentum: suggestions for treatment policy updates in the final push to eliminate malaria in India. Malar J. 2023;22:128.

Srivastava A, Nagpal BN, Joshi PL, Paliwal JC, Dash AP. Identification of malaria hot spots for focused intervention in tribal state of India: a GIS based approach. Int J Health Geogr. 2009;8:30.

Dhiman RC, Singh P, Yadav Y, Saraswat S, Kumar G, Singh RK, et al. Preparedness for malaria elimination in the wake of climate change in the State of Uttarakhand (India). J Vector Borne Dis. 2019;56:46-52.

Anvikar AR, Sharma B, Sharma SK, Ghosh SK, Bhatt RM, Kumar A, et al. In vitro assessment of drug resistance in Plasmodium falciparum in five States of India. Indian J Med Res. 2012;135:494-9.

Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455-67.

Baird JK. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother. 2004;48:4075-83.

MOHFW. Drug Policy for treatment of malaria: 2013. Available at: https://ncvbdc.mohfw.gov. in/WriteReadData/l892s/National-Drug-Policy-2013.pdf. Accessed on 02 October 2023.

Anvikar AR, Arora U, Sonal GS, Mishra N, Shahi B, Savargaonkar D, et al. Antimalarial drug policy in India: past, present & future. Indian J Med Res. 2014;139:205-15.

Downloads

Published

2023-11-14

How to Cite

Kaur, P., & Verma, P. (2023). Strength in struggle: unravelling the journey of national vector borne disease control programme India: a comprehensive SWOT analysis. International Journal Of Community Medicine And Public Health, 10(12), 5084–5090. https://doi.org/10.18203/2394-6040.ijcmph20233543

Issue

Section

Review Articles